litlas
ログインアカウント作成

Tamas Hickish

1993–2024 年に発表

64
論文数
21,232
被引用数
53
h 指数
61
i10 指数

被引用数

Tamas Hickish の年別被引用数1939 年: 被引用 1 件1948 年: 被引用 1 件1990 年: 被引用 2 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 9 件1996 年: 被引用 20 件1997 年: 被引用 21 件1998 年: 被引用 29 件1999 年: 被引用 53 件2000 年: 被引用 56 件2001 年: 被引用 69 件2002 年: 被引用 72 件2003 年: 被引用 102 件2004 年: 被引用 100 件2005 年: 被引用 137 件2006 年: 被引用 129 件2007 年: 被引用 120 件2008 年: 被引用 97 件2009 年: 被引用 94 件2010 年: 被引用 110 件2011 年: 被引用 100 件2012 年: 被引用 89 件2013 年: 被引用 120 件2014 年: 被引用 141 件2015 年: 被引用 128 件2016 年: 被引用 131 件2017 年: 被引用 164 件2018 年: 被引用 125 件2019 年: 被引用 529 件2020 年: 被引用 560 件2021 年: 被引用 498 件2022 年: 被引用 366 件2023 年: 被引用 267 件2024 年: 被引用 463 件2025 年: 被引用 216 件2026 年: 被引用 6 件1940〜1947 年は被引用が無いため表示していません1949〜1989 年は被引用が無いため表示していません1991〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,700 件、この内訳の 22.1%イギリス: 引用元論文 636 件、この内訳の 8.3%中国: 引用元論文 556 件、この内訳の 7.2%イタリア: 引用元論文 493 件、この内訳の 6.4%ドイツ: 引用元論文 433 件、この内訳の 5.6%フランス: 引用元論文 411 件、この内訳の 5.4%日本: 引用元論文 317 件、この内訳の 4.1%スペイン: 引用元論文 283 件、この内訳の 3.7%オランダ: 引用元論文 266 件、この内訳の 3.5%カナダ: 引用元論文 228 件、この内訳の 3%ベルギー: 引用元論文 215 件、この内訳の 2.8%オーストラリア: 引用元論文 202 件、この内訳の 2.6%
0%22.1%その他 25.3%

機関

分野

  • Medicine74.4%
  • Biochemistry, Genetics and Molecular Biology18.7%
  • Immunology and Microbiology2.2%
  • Computer Science1%
  • Engineering0.7%
  • Materials Science0.6%
  • その他2.4%

トピック

  • Colorectal Cancer Treatments and Studies7.9%
  • Colorectal Cancer Surgical Treatments5.3%
  • Breast Cancer Treatment Studies4%
  • Cholangiocarcinoma and Gallbladder Cancer Studies3.6%
  • HER2/EGFR in Cancer Research3.3%
  • Gastric Cancer Management and Outcomes3.2%
  • その他72.7%

共著者

全論文

検索で開く
  1. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

    著者: John N Primrose, Richard Fox, Daniel H. Palmer, Hassan Malik, Rajendra Prasad, Darius Mirza, Alan Anthony, Pippa Corrie, Stephen Falk, Meg Finch-Jones, Harpreet Wasan, Paul J. Ross, Lucy Wall, Jonathan Wadsley, JEFF EVANS, Deborah Stocken, Raaj Praseedom, Yuk Ting, Brian R Davidson, John P. Neoptolemos, Timothy Iveson, James Raftery, Shihua Zhu, David Cunningham, O. James Garden, Clive Stubbs, Juan W. Valle, John Bridgewater, John Primrose, RP Fox, Helen Morement, Oscar S.H. Chan, C. Rees, Ma Yt, Tamas Hickish, Stephen Falk, Meg Finch-Jones, Ian Pope, Pippa Corrie, Tom Crosby, S. Sothi, K Sharkland, Douglas Adamson, Lucy Wall, JEFF EVANS, John Dent, U. Hombaiah, Chinenye Iwuji, Alan Anthoney, John Bridgewater, David Cunningham, Roopinder Gillmore, Paul J. Ross, S. Slater, Harpreet Wasan, Jill Waters, Juan W. Valle, Daniel H. Palmer, Hafiz Malik, John P. Neoptolemos, Olusola Olusesan Faluyi, Kate Sumpter, U. Dernedde, S Maduhusudan, G. Cogill, Caroline Archer, Timothy Iveson, Jonathan Wadsley, Suzanne Darby, Mike Peterson, AA Mukhtar, JG Thorpe, Adrian C Bateman, D. Tsang, S. Cummins, L. Nolan, Éric Beaumont, Rajendra Prasad, D. Mirza, Deborah Stocken, Raaj Praseedom, Brian R Davidson, James Raftery, Shihua Zhu, James Garden, C Stubbs, Fareeda Y. Coxon - The Lancet Oncology 2019 被引用: 1,228

  2. Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

    著者: Thierry André, C. Boni, Lamia Mounedji-Boudiaf, Matilde Navarro, Josep Tabernero, Tamas Hickish, C. Topham, Marta Zaninelli, Philip R. Clingan, John Bridgewater, Isabelle Tabah-Fisch, Aimery de Gramont - New England Journal of Medicine 2004 被引用: 3,658

  3. Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer

    著者: Nicholas C. Turner, Claire Swift, Ben Jenkins, Lucy Kilburn, Maria Coakley, Matthew Beaney, Lisa Fox, Kate Goddard, Isaac García-Murillas, Paula Proszek, Peter S Hall, Catherine Harper‐Wynne, Tamas Hickish, Sarah Kernaghan, Iain R. Macpherson, Alicia Okines, Carlo Palmieri, Sophie Perry, Kat Randle, Claire Snowdon, Hilary Stobart, Andrew Wardley, Duncan Wheatley, Simon Waters, Matthew Winter, Michael Hubank, Steven Allen, Judith M. Bliss, Shing Leng Chan, Anne Armstrong, F. Raja, Peter Schmid, Andrew Tutt, René L. Roux, Susan Cleator - Annals of Oncology 2022 被引用: 191

  4. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

    著者: Andreas Schneeweiß, Stephen Chia, Tamas Hickish, V. Harvey, Alexandru Eniu, Roberto Hegg, Christoph Tausch, Jae Hong Seo, Y.-F. Tsai, Jayantha Ratnayake, Virginia McNally, G. Ross, Javier Cortés - Annals of Oncology 2013 被引用: 1,274

  5. Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

    著者: Thierry André, C. Boni, Matilde Navarro, Josep Tabernero, Tamas Hickish, C. Topham, Andrea Bonetti, Philip R. Clingan, John Bridgewater, Fernando Rivera, Aimery de Gramont - Journal of Clinical Oncology 2009 被引用: 2,292

  6. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study

    著者: Thierry André, Armand de Gramont, Déwi Vernerey, Benoist Chibaudel, Franck Bonnetain, Annemilaï Tijeras‐Raballand, Aurélie Scriva, Tamas Hickish, Josep Tabernero, Jean‐Luc Van Laethem, Maria Banzi, E. Maartense, Einat Shmueli, Göran Carlsson, Werner Scheithauer, Demetris Papamichael, M. Moehler, Stefania Landolfi, Pieter Demetter, Soudhir Colote, Christophe Tournigand, Christophe Louvet, Alex Duval, Jean-François Fléjou, Aimery de Gramont - Journal of Clinical Oncology 2015 被引用: 675

  7. Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

    著者: Gary Middleton, Paul Silcocks, Trevor F. Cox, Juan W. Valle, Jonathan Wadsley, David Propper, Fareeda Y. Coxon, Paul J. Ross, Srinivasan Madhusudan, Tom Roques, David Cunningham, Stephen Falk, Nick Wadd, Mark Harrison, Pippa Corrie, Timothy Iveson, Angus Robinson, Karen McAdam, Martin Eatock, JEFF EVANS, Caroline Archer, Tamas Hickish, Angel Garcia-Alonso, M. Nicolson, William P. Steward, Alan Anthoney, William Greenhalf, Victoria Shaw, Eithne Costello, Dean J. Naisbitt, Charlotte Rawcliffe, Gemma Nanson, John P. Neoptolemos - The Lancet Oncology 2014 被引用: 374

  8. Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer

    著者: Andreas Schneeweiß, Stephen Chia, Tamas Hickish, Vernon Harvey, Alexandru Eniu, Maeve Waldron-Lynch, Jennifer Eng‐Wong, S Kirk, Javier Cortés - European Journal of Cancer 2017 被引用: 283

  9. Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial

    著者: Janusz Jankowski, John de Caestecker, Sharon Love, Gavin Reilly, Peter J. Watson, S. Sanders, Yeng Ang, Danielle Morris, Pradeep Bhandari, Claire Brooks, Stephen Attwood, Rebecca Harrison, Hugh Barr, Paul Moayyedi, Krish Ragunath, Bashir Rameh, Grant Fullarton, Art Tucker, Ian Penman, Colin Rodgers, James Neale, Cathryn Edwards, Adelyn Wise, Stephen Jones, Nicholas Church, Kishor Vaidya, Sherzad Balata, John A. Todd, Michael Gibbons, David Johnston, Mark Anderson, Gareth Davies, William Dickey, A Murdock, G. A. Turner, Andrew Goddard, Stephen Gore, Chris Haigh, Timothy Harding, L. Jackson, Iain Murray, Joy Worthingon, Thomas Lee, Peik Loon Lim, James McLoughlin, Christopher Macdonald, Philip Mairs, David Gabriel Monk, Sean Preston, Stirling Pugh, Howard Smart, Ashraf Soliman, Peter Isaacs, David Aldulaimi, Nigel Trudgill, Julian Teare, A. Ben-Hamida, Andrew Bell, Robert Boulton-Jones, Tawfique K. Daneshmend, Hisaharu Suzuki, Sue Cullen, Rebecca C. Fitzgerald, Rupert Ransford, Mohammad Mesbahur Rahman, Giovanni Domenico Tebala, M. Hallissey, Carrie Kelly, Tamas Hickish, Ali S. Taha, J. W. Rademaker, M. Whitehead, Sean G. Kelly, Perminder Phull, Naveen Sharma, Ian Perry, Vankatraman Sankara-Raman, Haythem Ali, Iqbal Ansary Khan, Howard Curtis, Martin Wadley, Adam Stone, Sumesh Sukumaran, Andrew Higham, Stephen F. Lewis, Adam Haycock, Bernhard Usselmann, Simon D. Johnston, Tony Tham, S. Campbell, Andrew Douds, Jason Dunn, Ian Sargeant, Mark Narain, Nick Maynard, Andrew Chilton, Susi Green, Duncan E. Loft, Bart Decadt, Michael A. Mendall ほか 2 名 - The Lancet 2018 被引用: 265

  10. The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer

    著者: Jean Abraham, Karen Pinilla, Alimu Dayimu, Louise Grybowicz, Nikolaos Demiris, Caron Harvey, Lynsey M. Drewett, Rebecca Lucey, Alexander Fulton, Anne N. Roberts, Joanna R. Worley, Anita Chhabra, Wendi Qian, Anne-Laure Vallier, Richard M. Hardy, Steve Chan, Tamas Hickish, Devashish Tripathi, Ramachandran Venkitaraman, Mojca Persic, Shahzeena Aslam, Daniel Glassman, Sanjay Raj, Annabel Borley, Jeremy Braybrooke, Stephanie Sutherland, Emma Staples, Lucy Scott, Mark Davies, Cheryl A. Palmer, Margaret Moody, Mark Churn, Jacqueline C. Newby, Mukesh B. Mukesh, Amitabha Chakrabarti, Rebecca Roylance, Philip C. Schouten, N C Levitt, Karen McAdam, Anne Armstrong, Ellen Copson, Emma McMurtry, Marc Tischkowitz, Elena Provenzano, Helena Earl - Nature 2024 被引用: 47

  11. Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer

    著者: Maria Coakley, Guillermo Villacampa, Prithika Sritharan, Claire Swift, Kathryn Dunne, Lucy Kilburn, Katie Goddard, Christodoulos Pipinikas, Patricia Rojas, Warren Emmett, Peter S Hall, Catherine Harper‐Wynne, Tamas Hickish, Iain R. Macpherson, Alicia Okines, Andrew Wardley, Duncan Wheatley, Simon Waters, Carlo Palmieri, Matthew Winter, Rosalind Cutts, Isaac García-Murillas, Judith M. Bliss, Nicholas C. Turner - Clinical Cancer Research 2023 被引用: 44

  12. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

    著者: John Bridgewater, S. Pugh, Tom Maishman, Zina Eminton, J. M. MELLOR, Amy Whitehead, Louise Stanton, M Radford, Andrea Corkhill, Gareth Griffiths, Stephen Falk, Juan W. Valle, Derek O’Reilly, Ajith K. Siriwardena, Joanne Hornbuckle, Myrddin Rees, Timothy Iveson, Tamas Hickish, O. James Garden, David Cunningham, Tim Maughan, John N Primrose, Alaaeldin Shablack, Ann O’Callaghan, Anne Marie Moody, Alex Allen, A. Brewster, Alison Brown, Astrid Mayer, Brian R Davidson, Chan Ton, Charles Wilson, C. Lowdell, Charlotte Rees, Christopher Baughan, Clare Barlow, Colin Purcell, David Smith, David Tsang, Ewan Brown, Georgina Walker, Hassan Malik, Iain Cameron, Luke Nolan, Marcia Hall, Marjorie Tomlinson, Mark Hill, Mark Peterson, Meg Finch-Jones, Nagappan Kumar, N D Karanjia, Nasim Ali, Nigel Heaton, Nua Chan Ton, Paul J. Ross, Raaj Praseedom, Robert Thomas, Sally Clive, Sarah Slater, Sarah Smith, Satvinder Mudan, Satya Bhattacharya, Sharadah Essapen, Sherif Raouf, Stephen W. Fenwick, Susan Cleator, Tom Diamond, Vanessa Potter - The Lancet Oncology 2020 被引用: 239

  13. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial

    著者: John Primrose, Stephen Falk, Meg Finch-Jones, Juan W. Valle, Derek O’Reilly, Ajith K. Siriwardena, Joanne Hornbuckle, Mark Peterson, Myrddin Rees, Timothy Iveson, Tamas Hickish, Rachel Butler, Louise Stanton, Elizabeth Dixon, Louisa Little, Megan Bowers, S. Pugh, O. James Garden, David Cunningham, Tim Maughan, John Bridgewater - The Lancet Oncology 2014 被引用: 433

  14. Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial

    著者: Christophe Tournigand, Thierry André, Franck Bonnetain, Benoist Chibaudel, Gérard Lledo, Tamas Hickish, Josep Tabernero, C. Boni, Jean‐Baptiste Bachet, Luís Teixeira, Aimery de Gramont - Journal of Clinical Oncology 2012 被引用: 390

  15. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

    著者: Harpreet Wasan, Peter Gibbs, Navesh Sharma, Julien Taı̈eb, Volker Heinemann, Jens Ricke, Marc Peeters, Michael Findlay, Andrew Weaver, Jamie Mills, Charles Wilson, Richard Adams, Anne Francis, Joanna Moschandreas, Pradeep S. Virdee, Peter Dutton, Sharon Love, Val Gebski, Alastair Gray, Richard Adams, Andrew Bateman, Claire Blesing, Ewan Brown, Ian Chau, Sebastian Cummins, David Cunningham, Stephen Falk, Maher Hadaki, Marcia Hall, Tamas Hickish, Joanne Hornbuckle, F. Lofts, Sarah Lowndes, Astrid Mayer, Matthew S. Metcalfe, Gary Middleton, Jamie Mills, Amir Montazeri, R. Muirhead, Andreas Polychronis, Colin Purcell, Paul J. Ross, Ricky A. Sharma, Liz Sherwin, David Smith, Rubin Soomal, Daniel Swinson, Axel Walther, Harpreet Wasan, Andrew Weaver, Charles Wilson, Greg Wilson, Pradip Amin, Bruna Angelelli, Jacques Balosso, Alex Beny, Daniel Bloomgarden, Evelyn Boucher, Michael D. Brown, Harald-Robert Bruch, James Bui, Matthew Burge, Giuseppe Cardaci, James Carlisle, Seungjean Chai, Yi‐Jen Chen, P. Chevallier, Michael Chuong, Stephen Clarke, Andrew L. Coveler, M Craninx, Thierry Delanoit, Amélie Deleporte, Paul Eliadis, Francis Facchini, Thomas W. Ferguson, Michel Ferrante, Michael Findlay, Gary Frenette, Jacob Frick, Vinod Ganju, Michael Garofalo, Karen Geboes, Gerald Gehbauer, Benjamin George, Ravit Geva, Peter Gibbs, Melita A. Gordon, Kate Gregory, Seza A. Güleç, James Hannigan, Guy van Hazel, Norman Heching, Volker Heinemann, Thomas Helmberger, Alain Hendlisz, Koen Hendrickx, Matthew P. Holtzman, Richard Isaacs, Christopher Jackson ほか 156 名 - The Lancet Oncology 2017 被引用: 398

  16. Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

    著者: Alistair Ring, Lucy Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr, Andrew Wardley, Bora Gürel, Iain R. Macpherson, Ruth Riisnaes, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew Winter, Kathryn Dunne, Ellen Copson, Tamas Hickish, Russell Burcombe, Kat Randle, Violeta Serra, Alba Llop‐Guevara, Judith M. Bliss, Nicholas C. Turner - Clinical Cancer Research 2023 被引用: 36

  17. 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

    著者: Timothy Iveson, Rachel Kerr, Mark Saunders, Jim Cassidy, Niels Henrik Holländer, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Claire Scudder, Kathleen Boyd, Andrew Briggs, Ashita Waterston, Louise Medley, Charles B. Wilson, Richard Ellis, Sharadah Essapen, A.S. Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K Olesen, David Propper, John Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet Wasan, James Paul - The Lancet Oncology 2018 被引用: 188

  18. MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study

    著者: Tamas Hickish, Thierry André, Lucjan Wyrwicz, Mark Saunders, Tomasz Sarosiek, Judit Kocsis, Radim Němeček, Wojciech Rogowski, Krzysztof Leśniewski-Kmak, Luboš Petruželka, Ron N. Apte, Prasant Mohanty, Michael Stecher, John Simard, Aimery de Gramont - The Lancet Oncology 2017 被引用: 160

  19. A meta‐analysis of prevalence rates and moderating factors for cancer‐related post‐traumatic stress disorder

    著者: Gareth Abbey, Simon B. N. Thompson, Tamas Hickish, David Heathcote - Psycho-Oncology 2014 被引用: 275

  20. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

    著者: TJ Powles, Tamas Hickish, John А. Kanis, Alwynne Tidy, S. Ashley - Journal of Clinical Oncology 1996 被引用: 646

  21. Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer

    著者: Jens Huober, Eileen Holmes, José Baselga, Evandro de Azambuja, Michael Untch, Debora Fumagalli, Séverine Sarp, István Láng, Ian Smith, Frances Boyle, Binghe Xu, Christophe Lecocq, Hans Wildiers, Christelle Jouannaud, John Hackman, Lokanatha Dasappa, Eva Ciruelos, Juan Carlos Toral Peña, Hryhoriy Adamchuk, Tamas Hickish, Lorena de la Peña, Christian Jackisch, Richard D. Gelber, Martine Piccart, Serena Di Cosimo - European Journal of Cancer 2019 被引用: 90

  22. Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial

    著者: Helena Earl, Louise Hiller, Janet Dunn, Clare Blenkinsop, Louise Grybowicz, Anne-Laure Vallier, Jean Abraham, Jeremy Thomas, Elena Provenzano, Luke Hughes‐Davies, Ioannis Gounaris, Karen McAdam, Stephen Chan, Rizvana Ahmad, Tamas Hickish, Stephen Houston, Daniel Rea, John M.S. Bartlett, Carlos Caldas, David Cameron, Larry Hayward - The Lancet Oncology 2015 被引用: 134

  23. Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer

    著者: H. Raza Ali, Aliakbar Dariush, Elena Provenzano, Helen Bardwell, Jean Abraham, Mahesh Iddawela, Anne-Laure Vallier, Louise Hiller, Janet Dunn, S. Bowden, Tamas Hickish, Karen McAdam, Stephen Houston, M. J. Irwin, Paul D.P. Pharoah, James D. Brenton, N. A. Walton, Helena Earl, Carlos Caldas - Breast Cancer Research 2016 被引用: 90

  24. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

    著者: David Cunningham, Seppo Pyrhönen, R.D. James, Cornelis J.A. Punt, Tamas Hickish, Reino Heikkilä, Tom Børge Johannesen, Hans Starkhammar, C. Topham, Lucile Awad, Christian Jacques, Patrice Herait - The Lancet 1998 被引用: 1,259